Abstract
BackgroundMajor limiting factors for cell therapy in solid tumors include clonal heterogeneity and the related lack of universally expressed tumor-specific antigens. As the only truly polyclonal cell product in advanced...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have